Cmed Group, a full service CRO specializing in complex early phase trials, has entered into a strategic partnership with a top five pharmaceutical company to provide data capture and management services to support their early phase (Phase I, II, Proof of Concept) clinical trial pipeline.
Under the three year agreement, Cmed will provide data capture and management using its technologies, and will also collaborate on process and technology innovations to help improve and speed data visibility for critical decision making.
Dr. David Connelly, Cmed’s chief executive officer, said, “One of the key drivers for our client was the need for a responsive partner to provide flexible, high quality, efficient services for their fast paced, high throughput early phase pipeline. We are therefore delighted our client chose Cmed to form a strategic partnership so we can develop an already effective and efficient collaboration managing clinical data from our early phase trials into something that is truly smart and world class. We are confident that together, with our existing and emerging technologies and approaches, we can transform the setup, collection, management and review of clinical trial data.”